Position history for VANGUARD GROUP INC's holdings in ARCUTIS BIOTHERAPEUTICS INC
VANGUARD GROUP INC holds 7.3M shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), worth $210.7M as of 2025-Q4. The position was increased (++1.5% shares). ARQT represents 0.0% of VANGUARD GROUP INC's portfolio.
Current Value
$210.7M
Current Shares
7.3M
Total Value Change
+$145.9M
Total Shares Change
+291,301
Other major holders of ARQT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 7.3M |
+1.5% |
| $210.7M |
| 0.0% |
| $28.08 |
31 |
| 2025-Q3 | Increased | 7.1M | +1.4% | $134.7M | 0.0% | $18.62 | 31 |
| 2025-Q2 | Increased | 7M | +3.4% | $98.8M | 0.0% | $13.74 | 31 |
| 2025-Q1 | Increased | 6.8M | +5.9% | $106.6M | 0.0% | $15.73 | 32 |
| 2024-Q4 | Decreased | 6.4M | -7.5% | $89.7M | 0.0% | $14.20 | 0 |
| 2024-Q3 | New | 7M | - | $64.8M | 0.0% | $9.36 | 41 |